Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lip and oral cavity cancer
Trial Type:  Prevention
Results 1-6 of 6 for your search:
Start Over
Metformin Hydrochloride in Preventing Oral Cancer in Patients with an Oral Premalignant Lesion
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: UAZ2015-05-02, NCI-2015-01733, HHSN2612012000311, NCT02581137
A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Status: Active
Phase: Phase II
Type: Prevention, Supportive care
Age: 18 and over
Trial IDs: GT-201, NCI-2015-02173, NCT02508389
Defined Green Tea Catechin Extract and Erlotinib Hydrochloride in Treating Patients with Premalignant Lesions or Previously Treated Early Stage Squamous Cell Cancer of the Head and Neck
Status: Active
Phase: Phase I
Type: Prevention
Age: 18 and over
Trial IDs: WCI1549-08, NCI-2011-03396, WCI 1549, IRB00014010, NCT01116336
Vandetanib in Preventing Head and Neck Cancer in Patients with Precancerous Head and Neck Lesions
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 11-0265, NCI-2011-01246, NCT01414426
Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 40
Trial IDs: OSU-14135, NCI-2014-02622, 2014C0096, NCT02439255
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008
Start Over